PHARMA
Quarterly rpt on consolidated results for the financial period ended 30/6/2009
PHARMANIAGA BERHAD |
Financial Year End | 31/12/2009 |
Quarter | 2 |
Quarterly report for the financial period ended | 30/06/2009 |
The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION30/06/2009 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
30/06/2009 | 30/06/2008 | 30/06/2009 | 30/06/2008 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
1 | Revenue | 333,212 | 353,465 | 646,928 | 663,115 |
2 | Profit/(loss) before tax | 24,337 | 21,088 | 44,521 | 48,462 |
3 | Profit/(loss) for the period | 18,523 | 13,457 | 33,216 | 32,439 |
4 | Profit/(loss) attributable to ordinary equity holders of the parent | 17,697 | 13,107 | 32,219 | 31,652 |
5 | Basic earnings/(loss) per share (sen) | 16.54 | 12.25 | 30.12 | 29.59 |
6 | Proposed/Declared dividend per share (sen) | 27.00 | 18.00 | 27.00 | 18.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net assets per share attributable to ordinary equity holders of the parent (RM) | 3.7400 | 3.6300 |
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Remarks : |
Announcement Info
Company Name | PHARMANIAGA BERHAD |
Stock Name | PHARMA |
Date Announced | 21 Aug 2009 |
Category | Financial Results |
Reference No | PB-090818-D9224 |